Cargando…
Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia
BACKGROUND: Innovative and cost-effective strategies that clear asymptomatic malaria infections are required to reach malaria elimination goals, but remain a challenge. This mixed methods study explored people’s attitudes towards the reactive treatment of compound contacts of malaria cases with a 3-...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378745/ https://www.ncbi.nlm.nih.gov/pubmed/30777112 http://dx.doi.org/10.1186/s12936-019-2672-7 |
_version_ | 1783395978929242112 |
---|---|
author | Jaiteh, Fatou Masunaga, Yoriko Okebe, Joseph D’Alessandro, Umberto Balen, Julie Bradley, John Gryseels, Charlotte Ribera, Joan Muela Grietens, Koen Peeters |
author_facet | Jaiteh, Fatou Masunaga, Yoriko Okebe, Joseph D’Alessandro, Umberto Balen, Julie Bradley, John Gryseels, Charlotte Ribera, Joan Muela Grietens, Koen Peeters |
author_sort | Jaiteh, Fatou |
collection | PubMed |
description | BACKGROUND: Innovative and cost-effective strategies that clear asymptomatic malaria infections are required to reach malaria elimination goals, but remain a challenge. This mixed methods study explored people’s attitudes towards the reactive treatment of compound contacts of malaria cases with a 3-day course of dihydroartemisinin-piperaquine (DHAP), the socio-cultural representations of asymptomatic infections, and more specifically their treatment. METHODS: Prior to the start of the intervention, a sequential mixed method study was carried out. Qualitative data collection involved in-depth interviews and participant observations (including informal conversations) with key informants from the trial communities and the trial staff. Quantitative data were derived from a pre-trial cross-sectional survey on health literacy and health-seeking behaviour among randomly selected members of the study communities. RESULTS: In the pre-trial cross-sectional survey, 73% of respondents reported that malaria could be hidden in the body without symptoms. Whilst this may be interpreted as people’s comprehension of asymptomatic malaria, qualitative data indicated that informants had different interpretations of asymptomatic disease than the biomedical model. It was described as: (i) a minor illness that does not prevent people carrying out daily activities; (ii) an illness that oscillates between symptomatic and asymptomatic phases; and, (iii) a condition where disease agents are present in the body but remain hidden, without signs and symptoms, until something triggers their manifestation. Furthermore, this form of hidden malaria was reported to be most present in those living in the same compound with a malaria case (71%). CONCLUSION: Treating asymptomatic malaria with pharmaceuticals was considered acceptable. However, people felt uncertain to take treatment without screening for malaria first, largely due to the lack of symptoms. Knowledge of asymptomatic malaria was not a strong re-inforcement for treatment adherence. In this study, the pre-intervention active engagement of communities existed of having people co-design accurate information messages about their personal risk of malaria, which increased their trust in expert knowledge and thus proved essential for the successful implementation of the community-based intervention. |
format | Online Article Text |
id | pubmed-6378745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63787452019-02-28 Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia Jaiteh, Fatou Masunaga, Yoriko Okebe, Joseph D’Alessandro, Umberto Balen, Julie Bradley, John Gryseels, Charlotte Ribera, Joan Muela Grietens, Koen Peeters Malar J Research BACKGROUND: Innovative and cost-effective strategies that clear asymptomatic malaria infections are required to reach malaria elimination goals, but remain a challenge. This mixed methods study explored people’s attitudes towards the reactive treatment of compound contacts of malaria cases with a 3-day course of dihydroartemisinin-piperaquine (DHAP), the socio-cultural representations of asymptomatic infections, and more specifically their treatment. METHODS: Prior to the start of the intervention, a sequential mixed method study was carried out. Qualitative data collection involved in-depth interviews and participant observations (including informal conversations) with key informants from the trial communities and the trial staff. Quantitative data were derived from a pre-trial cross-sectional survey on health literacy and health-seeking behaviour among randomly selected members of the study communities. RESULTS: In the pre-trial cross-sectional survey, 73% of respondents reported that malaria could be hidden in the body without symptoms. Whilst this may be interpreted as people’s comprehension of asymptomatic malaria, qualitative data indicated that informants had different interpretations of asymptomatic disease than the biomedical model. It was described as: (i) a minor illness that does not prevent people carrying out daily activities; (ii) an illness that oscillates between symptomatic and asymptomatic phases; and, (iii) a condition where disease agents are present in the body but remain hidden, without signs and symptoms, until something triggers their manifestation. Furthermore, this form of hidden malaria was reported to be most present in those living in the same compound with a malaria case (71%). CONCLUSION: Treating asymptomatic malaria with pharmaceuticals was considered acceptable. However, people felt uncertain to take treatment without screening for malaria first, largely due to the lack of symptoms. Knowledge of asymptomatic malaria was not a strong re-inforcement for treatment adherence. In this study, the pre-intervention active engagement of communities existed of having people co-design accurate information messages about their personal risk of malaria, which increased their trust in expert knowledge and thus proved essential for the successful implementation of the community-based intervention. BioMed Central 2019-02-18 /pmc/articles/PMC6378745/ /pubmed/30777112 http://dx.doi.org/10.1186/s12936-019-2672-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Jaiteh, Fatou Masunaga, Yoriko Okebe, Joseph D’Alessandro, Umberto Balen, Julie Bradley, John Gryseels, Charlotte Ribera, Joan Muela Grietens, Koen Peeters Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia |
title | Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia |
title_full | Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia |
title_fullStr | Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia |
title_full_unstemmed | Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia |
title_short | Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia |
title_sort | community perspectives on treating asymptomatic infections for malaria elimination in the gambia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378745/ https://www.ncbi.nlm.nih.gov/pubmed/30777112 http://dx.doi.org/10.1186/s12936-019-2672-7 |
work_keys_str_mv | AT jaitehfatou communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia AT masunagayoriko communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia AT okebejoseph communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia AT dalessandroumberto communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia AT balenjulie communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia AT bradleyjohn communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia AT gryseelscharlotte communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia AT riberajoanmuela communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia AT grietenskoenpeeters communityperspectivesontreatingasymptomaticinfectionsformalariaeliminationinthegambia |